The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches

The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches

10.1002/med.20254

Saved in:

Bibliographic Details
Main Authors:	Cheong, S.L., Federico, S., Venkatesan, G., Mandel, A.L., Shao, Y.-M., Moro, S., Spalluto, G., Pastorin, G.
Other Authors:	PHARMACY
Format:	Article
Published:	2014
Subjects:	Agonist Allosteric modulator Antagonist Human A3 adenosine receptor Molecular modeling Pharmacology Therapeutic potential
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/116621
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

DESIGN, SYNTHESIS, PHARMACOLOGICAL AND MOLECULAR MODELING EVALUATION OF NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AS HUMAN A3 ADENOSINE RECEPTOR ANTAGONISTS
by: GOPALAKRISHNAN VENKATESAN
Published: (2014)

Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia
by: Wei, M.H., et al.
Published: (2011)

Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process
by: Pastorin, G., et al.
Published: (2014)

Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo- pyrimidines as potent human A3 adenosine receptor antagonists
by: Cheong, S.L., et al.
Published: (2014)

Adenosine and its receptor agonists regulate nitric oxide production in raw 264.7 Macrophages via both receptor binding and its downstream metabolites - Inosine
by: Khoo, H.E., et al.
Published: (2014)

Discovery of simplified N2-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: Efficient synthetic approaches, biological evaluations and molecular docking studies
by: Venkatesan, G., et al.
Published: (2014)

Does the combination of optimal substitutions at the C 2-, N 5- and N 8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A 3 adenosine receptors?
by: Cheong, S.L., et al.
Published: (2014)

The role of adenosine, adenosine receptors and transporters in the modulation of cell death
by: SUN WENTIAN
Published: (2010)

Concentrative transport of adenosine in murine splenocytes: Limitation by an ecto-adenosine deaminase
by: Lee, C.-W., et al.
Published: (2014)

DESIGN, SYNTHESIS, PHARMACOLOGICAL AND MOLECULAR MODELING EVALUATIONS OF NEW PYRAZOLO-TRIAZOLO-PYRIMIDINE DERIVATIVES AS HUMAN A3 ADENOSINE RECEPTOR ANTAGONISTS
by: CHEONG SIEW LEE
Published: (2011)

Organoruthenium antagonists of human A3 adenosine receptors
by: Paira, P., et al.
Published: (2014)

Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A2A and A3 receptor pyrazolo-triazolo-pyrimidine antagonists binding sites
by: Michielan, L., et al.
Published: (2014)

Expression of inducible nitric oxide synthase in mice: Pharmacological evaluation of adenosine receptor agonists
by: Moochhala, S.M., et al.
Published: (2014)

Potential therapeutic effects of oximes
by: LOKE WENG KEONG
Published: (2010)

Adenosine induced apoptosis in BHK cells via P1 receptors and equilibrative nucleoside transporters
by: Sun, W., et al.
Published: (2013)

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
by: Tay, Apple Hui Min, et al.
Published: (2023)

Asthma - New drugs on the horizon?
by: Hui, K.P.
Published: (2014)

THE IMPORTANCE OF AN ALLOSTERIC POCKET IN THE DENGUE PROTEASE
by: NOEMI REBECCA MEIER
Published: (2013)

Design, synthesis and evaluation of new indolylpyrimidylpiperazines for gastrointestinal cancer therapy
by: Tan, A., et al.
Published: (2021)

Modulation of DNA synthesis via adenosine receptors in human epidermoid carcinoma (A431) cells
by: Tey, H.-B., et al.
Published: (2014)

Poly(adenosine diphosphate-ribose) polymerase expression in human traumatic brain injury
by: Ang, B.T., et al.
Published: (2014)

Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa
by: Khoo, H.-E., et al.
Published: (2014)

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: A prospective randomized study
by: Lee, C.-H., et al.
Published: (2014)

Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocket
by: Kannan, Srinivasaraghavan, et al.
Published: (2018)

Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
by: Qvortrup, Katrine, et al.
Published: (2017)

DISCOVERY OF INDOLYL PIPERAZINYLPYRIMIDINES WITH DUAL-TARGET PROFILES ADENOSINE A2¿ AND DOPAMINE D2 RECEPTORS FOR PD TREATMENT
by: SHAO YI-MING
Published: (2015)

Evidence for A1 and A(2B) adenosine receptors in baby hamster kidney (BHK) cells
by: Mittal, R.A., et al.
Published: (2013)

A facile and novel synthesis of N2-, C6-substituted pyrazolo[3,4- d ]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists
by: Venkatesan G., et al.
Published: (2016)

Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease
by: Tan, E.K., et al.
Published: (2014)

Adenosine triphosphate synthase- A unique cellular power generator
by: Heralde, Francisco M., III
Published: (1998)

Adenosine and its receptor agonists potentiate nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages
by: Hon, W.-M., et al.
Published: (2014)

Predicting allosteric effects from orthosteric binding in Hsp90-ligand interactions : implications for fragment-based drug design
by: Chandramohan, Arun, et al.
Published: (2018)

Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs
by: Tang, F.R., et al.
Published: (2014)

Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis
by: Negatu, D.A., et al.
Published: (2022)

Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism
by: Kittipong Maneechotesuwan, et al.
Published: (2017)

Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites
by: Kumar, Ammu Prasanna, et al.
Published: (2020)

Pyruvate kinase regulates the pentose-phosphate pathway in response to hypoxia in mycobacterium tuberculosis
by: Zhong, Wenhe, et al.
Published: (2021)

Defining neutralization and allostery by antibodies against COVID-19 variants
by: Tulsian, Nikhil Kumar, et al.
Published: (2024)

Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human A3 adenosine receptor antagonists
by: Federico, S., et al.
Published: (2014)

Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
by: Tan, Chek Kun, et al.
Published: (2017)